Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Anti-TNF-alpha Antibody (7S35) is a Mouse antibody targeting TNF-alpha. Anti-TNF-alpha Antibody (7S35) can be used in ELISA,ELISA(Cap),FCM.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 20 μL | $94 | 7-10 days | |
| 100 μL | $292 | 7-10 days | 
| Description | Anti-TNF-alpha Antibody (7S35) is a Mouse antibody targeting TNF-alpha. Anti-TNF-alpha Antibody (7S35) can be used in ELISA,ELISA(Cap),FCM.  | 
| Ig Type | Mouse IgG1  | 
| Clone | 7S35  | 
| Reactivity | Human  | 
| Specificity | Human TNF-alpha  | 
| Verified Activity | Flow cytometric analysis of Purified anti-Human TNFa on CHO transfected cells and stimulated lymphocytes. Left panel The transfected cells stained with Purified Mouse anti-TNFa (Bold line hisgram), To demonstrate specificity of staining, the binding of Anti-TNF-alpha Antibody was blocked by the preincubation of the purified antibody with molar excess of recombinant human TNFa (5 μg) for 1 hour (dashed line hisgram), then stained with a FITC-conjugated second step antibody. Right panel Human PBMC were stimulated for 4 hrs with Leukocyte Activation Cocktail (with BD GolgiPlug™, BD Pharmingen™ Cat. No. 550583), then cells were harvested and treated according to manufacturer’s manual (BD Pharmingen™ Cat. No. 554714).  | 
| Application | |
| Recommended Dose | ELISA: 1:1000-1:2000; FCM: 1:25-1:100; ELISA(Cap): 1:250-1:2000  | 
| Antibody Type | Monoclonal  | 
| Host Species | Mouse | 
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Tumor necrosis factor-alpha (rhTNFα; TMPY-00936; Val 77-Leu 233; NP_000585.2). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. | 
| Purification | Protein A | 
| Appearance | Liquid | 
| Formulation | 0.2 μm filtered solution in PBS | 
| Research Background | Tumor necrosis factor alpha (TNF-alpha), also known as TNF, TNFA or TNFSF2, is the prototypic cytokine of the TNF superfamily, and is a multifunctional molecule involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. Two receptors, TNF-R1 (TNF receptor type 1; CD120a; p55/60) and TNF-R2 (TNF receptor type 2; CD120b; p75/80), bind to TNF-alpha. TNF-alpha protein is produced mainly by macrophages, and large amounts of this cytokine are released in response to lipopolysaccharide, other bacterial products, and Interleukin-1 (IL-1). TNF-alpha is involved in fighting against the tumorigenesis, thus, is regarded as a molecular insight in cancer treatment.TNF-alpha Protein & AntibodyCancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy | 
| Conjucates | Unconjugated  | 
| Others Formats | FITC  | 
| Antibody Types Available | 2  | 
| Immunogen | Recombinant Protein: Human TNFα protein (TMPY-00936)  | 
| Antigen Species | Human  | 
| Biology Area | Cancer Drug Targets, Neuroinflammation  | 
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. | 
| Transport | Shipping with blue ice. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.